$208.35
-0.75%
N/A-$1.57
Healthcare
Biotechnology
NASDAQ
활발히 거래 중
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) ...
Axsome Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for a range of central nervous system (CNS) ...
C-레벨 임원은 회사의 재무 전략과 혁신을 이끄는 응집된 리더십 팀입니다.
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Herriot Tabuteau | Founder, Chairman, Chief Executive Officer & President | USD 1,916,701 | — | 1968 | Active |
| Mark L. Jacobson | Chief Operating Officer | USD 1,058,568 | 1983 | Active | |
| Nick Pizzie | Chief Financial Officer | USD 974,594 | 1975 | Active | |
| Hunter Murdock | General Counsel & Secretary | USD 960,636 | 1980 | Active | |
| Ari Maizel | Chief Commercial Officer | USD 924,989 | 1979 | Active | |
| Darren Opland | Director of Corporate Communications | — | — | — | Active |
| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-24 | 2025 | Herriot Tabuteau, M.D. | Chief Chief Executive Officer, President President and Chairman of the Board | Founder / CEO | $835.00K | $0 | $5.53M | $2.83M | $876.75K | $204.95K | $10.28M |
| 2026-04-24 | 2025 | Mark Jacobson, M.A. | Chief Chief Operating Officer | C-Level | $575.00K | $0 | $2.08M | $1.07M | $388.00K | $95.57K | $4.21M |
| 2026-04-24 | 2025 | Nick Pizzie, C.P.A., M.B.A. | Chief Chief Financial Officer | C-Level | $530.00K | $0 | $1.82M | $933.33K | $358.00K | $86.59K | $3.73M |
| 2026-04-24 | 2025 | Hunter Murdock, Esq. | General General Counsel | Other | $530.00K | $0 | $1.50M | $766.59K | $358.00K | $72.64K | $3.22M |
| 2026-04-24 | 2025 | Ari Maizel, M.B.A. | Chief Chief Commercial Officer | C-Level | $530.00K | $0 | $1.50M | $766.59K | $358.00K | $36.99K | $3.19M |
| 2026-04-24 | 2024 | Herriot Tabuteau, M.D. | Chief Chief Executive Officer, President President and Chairman of the Board | Founder / CEO | $780.00K | $0 | $2.83M | $5.67M | $955.50K | $129.43K | $10.36M |
| 2026-04-24 | 2024 | Mark Jacobson, M.A. | Chief Chief Operating Officer | C-Level | $552.00K | $0 | $1.07M | $2.13M | $435.00K | $58.96K | $4.25M |
| 2026-04-24 | 2024 | Nick Pizzie, C.P.A., M.B.A. | Chief Chief Financial Officer | C-Level | $505.00K | $0 | $933.26K | $1.87M | $398.00K | $53.49K | $3.76M |
| 2026-04-24 | 2024 | Hunter Murdock, Esq. | General General Counsel | Other | $505.00K | $0 | $766.54K | $1.53M | $398.00K | $42.70K | $3.25M |
| 2026-04-24 | 2024 | Ari Maizel, M.B.A. | Chief Chief Commercial Officer | C-Level | $510.00K | $0 | $766.54K | $1.53M | $372.00K | $16.66K | $3.20M |
| 2026-04-24 | 2023 | Herriot Tabuteau, M.D. | Chief Chief Executive Officer, President President and Chairman of the Board | Founder / CEO | $750.00K | $0 | $2.83M | $5.67M | $562.50K | $82.96K | $9.90M |
| 2026-04-24 | 2023 | Mark Jacobson, M.A. | Chief Chief Operating Officer | C-Level | $530.00K | $0 | $1.07M | $2.13M | $265.00K | $40.84K | $4.04M |
| 2026-04-24 | 2023 | Ari Maizel, M.B.A. | Chief Chief Commercial Officer | C-Level | $445.00K | $0 | $1.08M | $2.15M | $250.00K | $0 | $3.92M |
| 2026-04-24 | 2023 | Nick Pizzie, C.P.A., M.B.A. | Chief Chief Financial Officer | C-Level | $485.00K | $0 | $933.66K | $1.87M | $243.00K | $37.48K | $3.57M |
| 2026-04-24 | 2023 | Hunter Murdock, Esq. | General General Counsel | Other | $485.00K | $0 | $766.91K | $1.53M | $243.00K | $29.31K | $3.06M |
Sum of disclosed compensation by year (USD million)
Top founder/C-level executives over time (USD million)